All News

The vaccine development company SingVax Pte Ltd. (Singapore, www.singvax.com) has named John Brown, PhD, as Chairman of the Board of Directors.

Aida Pharmaceuticals (Hangzhou, China) has completed its acquisition of majority control of Shanghai Qiaer Bio-Technology Co., Ltd (Shanghai, China).

AAIPharma (Wilmington, DE, www.aaipharma.com) has recently named several new vice presidents.

Fresenius Kabi (Bad Homburg, Germany, www.fresenius-kabi.com) and Sandoz, (Holzkirchen, Germany, www.sandoz.com), have entered into a partnership to develop a second-generation version of an un-named Sandoz recombinant protein using Fresenius Kabi's "HESylation" technology.

Vaccines made with bacteria killed by gamma rays may be more effective than those made using standard heat or chemical inactivation, according to Sandip Datta, MD, assistant professor in the department of medicine, University of California, San Diego (http://www.ucsd.edu).

QSV Biologics, Ltd. (Edmonton, Canada, www.qsvbiologics.com) has signed a contract with Tissue Therapies Limited (Brisbane, Australia, www.tissuetherapies.com) for the cGMP manufacture of clinical quantities of synthetic Vitronectin (a component of the wound-healing treatment VitroGro) and a single-protein chimeric form of VitroGro.

Cardinal Health (Dublin, OH, www.cardinalhealth.com) has appointed David H. Lees, PhD, president of Cardinal Health Canada.

Lpath, Inc. (San Diego, CA, www.lpath.com) and Laureate Pharma, Inc. (Princeton, NJ, www.laureatepharma.com) have entered into an agreement for Laureate to manufacture Lpath's recombinant humanized monoclonal antibody, "Sphingomab," against bioactive lipids.

Novexin (Cambridge, UK, www.novexin.com) has received an additional ?200,000 grant from the UK Department of Trade and Industry (DTI) to continue development of its carbohydrate polymers to enhance the solubility and stability of proteins in solution.

Cobra Biomanufacturing Plc (Keele, UK, www.cobrabio.com) has appointed Dr. John Lovelady as Director of Manufacturing Operations for the group.

The development of biotech drugs poses challenges that cross several disciplines.

FDA ordered Donor Referral Services (Raleigh, NC) and its owner, Philip Guyett, to immediately cease all manufacturing operations and to retain human cells, tissues, and cellular- and tissue-based products (HCT/Ps) after an inspection found serious deficiencies in its manufacturing practices, including those governing donor screening and record keeping.

Genelabs Technologies, Inc. (Redwood City, CA, www.genelabs.com) has appointed Peter R. Young, PhD, to the position of vice president, biology.

EduNeering (Princeton, NJ, www.eduneering.com) and the Food and Drug Administration (Washington, DC, www.fda.gov) have extended their existing Cooperative Research and Developing Agreement (CRADA), originally formed in 1999, for five more years.

The US Food and Drug Administration has approved MedImmune's (Gaithersburg, MD, www.medimmune.com) supplemental biologics license application to use reverse genetics technology to create new vaccine strains for their influenza vaccines, including the intranasal FluMist vaccine.

PRA International (Reston, VA, www.prainternational.com) has completed the acquisition of Pharma Bio-Research (Zuidlaren, The Netherlands), an early-phase clinical development and bioanalytical company.

The Associated Chambers of Commerce and Industry of India (Assocham, www.assocham.org) have called for the establishment of a National Biotechnology Development Fund and a National Nanotechnology Development Fund, with outlays of approximately US $1 billion (Rs. 4,800 crore) and US $2 billion (Rs. 9,600 crore) respectively.

Emisphere Technologies, Inc. (Tarrytown, NY, www.emisphere.com) has signed a multi-product research agreement with Roche (Basel, Switzerland, www.roche.com) to explore the use of Emisphere's eligen technology in feasibility studies for new oral formulations of Roche molecules.

The nanotechnology vision of tiny microrobots that could move inside the body carrying out complex surgical repairs has been touted incessantly until it has become a clich?.

Ray (Rui) Zhong has joined China Biopharmaceuticals Holdings, Inc. (CHBP)?(Beijing, China, www.cbioinc.com) as senior vice president, finance and business development.

Mark Goldberger has been named the first medical director for Emerging and Pandemic Threat Preparedness at the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration.

Plast-O-Matic Valves (Cedar Grove, NJ, www.plastomatic.com) offers a low-cost flow control valve in natural polypropylene, PVC, and other rugged thermoplastics to maintain a constant, pre-determined flow in a piping system.

Biotechnology and pharmaceutical companies seeking to train employees, or even to create their own "online university" can now partner with The Pharmaceutical Institute (PI, Raleigh, NC, www.pharmainstitute.com).

Envita Natural Centers of America (Scottsdale, AZ, www.behealthyamerica.com) received a warning letter from the FDA on June 14 that states that the firm's manufacturing process violates the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act.

Poniard Pharmaceuticals, Inc. (Seattle, WA, www.poniard.com) has appointed Alan B. Glassberg, MD, as its chief medical officer.

Biocon Ltd. (Bangalore, India, www.biocon.com) has signed a licensing agreement with Bayer Healthcare LLC (www.bayerhealth.com), a subsidiary of Bayer AG (Leverkusen, Germany) for exclusive rights for its branded recombinant human insulin, Insugen, in China.

Catherine Wachira has joined The US Pharmacopeia (USP, www.usp.org), as director of the Drug Quality and Information (DQI) program.

Buffett prefers to buy small, publicly traded companies with ample room for growth.

Northfield Laboratories Inc. (Evanston, IL, www.northfieldlabs.com) has agreed to purchase a building it previously leased in Mt. Prospect, IL, to house its first commercial manufacturing facility to produce PolyHeme, Northfield?s human hemoglobin-based oxygen carrier, used to treat urgent, large-volume blood loss in trauma and surgical settings.

BioFlo 310 Benchtop Fermentor; Chromatography Sorbents for Protein Purification